Oulu, Finland

Raili M Myllyla

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raili M Myllyla. Retrieved from https://idiyas.com/inventor/raili-m-myllyla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raili M Myllyla: Innovator in Oligopeptide Research

Introduction

Raili M Myllyla is a prominent inventor based in Oulu, Finland. She has made significant contributions to the field of biochemistry, particularly in the development of novel compounds that have potential therapeutic applications. Her work focuses on the synthesis and application of oligopetides with cyclic proline-analogous amino acids.

Latest Patents

Raili M Myllyla holds a patent for her invention titled "Oligopetides with cyclic proline-analogous amino acids." This patent describes compounds that can be utilized as inhibitors of prolyl hydroxylase. The compounds are characterized by a specific formula that includes various radicals and functional groups, showcasing her innovative approach to biochemical research. She has 1 patent to her name.

Career Highlights

Raili has worked with Hoechst Aktiengesellschaft, where she has been able to apply her expertise in a collaborative environment. Her research has contributed to advancements in the understanding of biochemical processes and the development of new therapeutic agents.

Collaborations

Throughout her career, Raili has collaborated with notable colleagues, including Stephan Henke and Dietrich Brocks. These partnerships have enhanced her research and expanded the impact of her inventions.

Conclusion

Raili M Myllyla is a distinguished inventor whose work in oligopetide research has the potential to influence therapeutic strategies in biochemistry. Her innovative contributions continue to pave the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…